Results showed that the reduction in SUA levels was not statistically different from placebo and that active controls, such as sodium-glucose co-transporter 2 (SGLT-2) inhibitors, were better at lowering SUA levels
Most clinical guidance recommends: At 3 months: A1c recheck (HbA1c reflects the prior 3-month average, making this the earliest timepoint for meaningful assessment of glycemic response), metabolic panel if any GI side effects were significant At 6 months: Full panel repeat A1c, CMP, lipids, CBC to document treatment response comprehensively Annually: Full panel plus thyroid function, B12, and any additional markers relevant to your individual health picture If you experience severe or persistent gastrointestinal side effects, signs of dehydration, unusual fatigue, or any concerning symptoms, kidney function should be rechecked without waiting for a scheduled interval
This targeted formula is perfect if you are looking for a potent dose of B12 and folate for your methylation-support protocol
Barretts esophagus is a condition in which the lining of the esophagus changes due to long-term acid damage
These issues can affect your diet, your social life, and even other areas of health
They are complementary tools, not alternatives, and understanding why requires looking more closely at what HRT actually does at the mechanistic level
